403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Clinical Trials Support Software Solutions In A $34.15B Trial Economy By 2035
(MENAFN- GlobeNewsWire - Nasdaq) The global clinical trials support software solutions market size was valued at USD 12.99 billion in 2025 and is predicted to hit around USD 34.15 billion by 2035, rising at a 10.15% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.
![]()
Ottawa, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The global clinical trials support software solutions market
Key Takeaways
- North America accounted for the largest share of the clinical trials support software solutions market in 2025. Asia Pacific is expected to grow at the fastest CAGR in the studied years. By product, the CTMS segment registered dominance in the market in 2025. By product, the payments/investigator payment solutions segment is expected to grow at the fastest CAGR in the studied years. By delivery mode, the cloud and web-based segment led the market in 2025. By delivery mode, the on-premise segment is expected to grow at a significant rate in the studied years. By phase, the phase III segment dominated the global market. By phase, the phase I segment is expected to grow at the fastest CAGR in the studied years. By end-use, the CROs segment led the market in 2025. By end-use, the biopharmaceutical companies segment is expected to grow at the fastest CAGR in the studied years.
What are Clinical Trials Support Software Solutions?
Clinical trial support solutions are digital platforms that streamline trial planning, patient recruitment data management, monitoring, and regulatory compliance to improve efficiency, accuracy, and outcomes across clinical research studies. The clinical trials support software solutions market is growing due to the increasing complexity of clinical studies and the rising demand for faster, more efficient trial execution. Widespread adoption of digital tools for patient recruitment, data management, and remote monitoring improves accuracy and compliance. Additionally, growing use of decentralized and hybrid trials, regulatory pressure for data transparency, and investments in life sciences
For Instance,
- In May 2025, the World Health Organization launched a global action plan aimed at strengthening clinical trial ecosystems worldwide. The initiative emphasizes wider use of digital technologies, improved transparency in trial registration and data sharing, and closer integration of clinical trials within national healthcare systems to enhance efficiency and research impact.
What are the Prominent Drivers in the Clinical Trials Support Software Solutions Market?
Prominent drivers of the market include the growing complexity of clinical studies and the increasing adoption of decentralized and hybrid trial models. Rising demand for faster patient recruitment, real-time data monitoring, and regulatory compliance is accelerating software adoption. Additionally, advancements in cloud computing, AI-driven analytics, and increasing investments in pharmaceutical
Let's discuss your needs, reach out to place your order today ...What are the Substantial Trends in the Clinical Trials Support Software Solutions Market?
- In November 2025, SAS launched SAS Clinical Acceleration to modernize clinical trial processes nd shorten time to market. Built on the AI and data analytics capabilities of SAS Viya, the solution simplifies drug development workflows, enabling life sciences companies to bring innovative therapies to patients more efficiently. In May 2025, PhaseV, a specialist in AI- and ML-enabled clinical development, closed a USD 50 million Series A funding round. The round was co-led by Accel and Insight Partners, with continued support from existing investors, increasing PhaseV's total funding to USD 65 million.
What is the Emerging Challenge in the Clinical Trials Support Software Solutions Market?
An emerging challenge in the market is encouraging data security and regulatory compliance while integrating multiple digital platforms. Managing large volumes of sensitive patient data, maintaining interoperability across systems, and addressing resistance to technology adoption among trial stakeholders continue to create implementation and scalability hurdles.
Regional Analysis
What Made North America Dominant in the Clinical Trials Support Software Solutions Market in 2025?
North America dominated the market in 2025 due to early adoption of advanced digital trials technology, strong presence of pharmaceutical and biotech companies, and high clinical trial activity. The region benefits from robust healthcare IT infrastructure, significant R&D investments, supportive regulatory frameworks, and widespread use of decentralized and data-driven trial models, which accelerated demand for efficient clinical trial software solutions.
For Instance,
- In July 2025, PhaseV introduced its ClinOps platform, a next-generation solution aimed at transforming clinical trial operations. The platform applies AI- and ML-driven insights to enable data-backed site selection and continuous performance tracking, helping sponsors optimize trial execution, improve operational efficiency, and enhance overall study outcomes.
In the U.S., clinical trials support software solutions are advancing with a strong emphasis on AI-driven analytics, decentralized trial models, and regulatory compliance platforms that enhance data integrity and streamline operations for drug developers and CROs. Continued digital transformation and venture capital interest are expanding innovation and adoption.
How did the Asia Pacific Expand At the Fastest Pace in the Market in 2025?
Asia Pacific expanded at the fastest pace globally in 2025 due to rapid growth in pharmaceutical and biotechnology research, increasing clinical trial activity, and rising adoption of digital health technologies. Expanding patent pools, cost-effective trial operations, supportive government initiatives, and growing investments in healthcare IT
In China, clinical trials support software solutions are growing rapidly as domestic pharmaceutical investment, government digital health
Number of trials by country or area from 1999-2025
Segmental Insights
By Product Insights
How did the CTMS Segment Dominate the Clinical Trials Support Software Solutions Market in 2025?
The clinical trial management system (CTMS) segment dominated the market in 2025 due to its ability to streamline end-to-end trial operations, including study planning, site management, patient recruitment, and regulatory compliance. High demand from pharmaceutical and biotechnology companies for efficient trial monitoring, centralized data management, and improved operational visibility contributed to the widespread adoption and leadership of CTMS solutions.
The payments/investigator payment solutions segment is expected to grow at the fastest CAGR during the forecast period due to the increasing complexity of clinical trial financial management and the need for timely, transparent payments to sites and investigators. Adoption of automated, digital payment platforms reduces administrative burden, enhances compliance, improves site engagement, and supports faster trial execution, driving strong demand across pharmaceutical and biotech companies globally.
By Delivery Mode Insights
Why the Cloud and Web-based Segment Dominated the Clinical Trials Support Software Solutions Market?
The cloud and web-based segment dominated the market due to its scalability, remote accessibility, and cost-effectiveness. These platforms enable real-time data sharing, centralized trial management, and seamless collaboration across sites and stakeholders. Additionally, growing adoption of decentralized and hybrid trials, combined with reduced IT infrastructure requirements and faster deployment, further strengthened the preference for cloud-and web-based solutions.
The on-premise segment is expected to grow at the fastest CAGR during the forecast period due to rising concerns over data security, privacy, and regulatory compliance in clinical trials. Organizations handling sensitive patient and trial data prefer on-premise solutions for greater control, customization, and integration with existing IT systems. Additionally, increased adoption by large pharmaceutical and biotechnology companies drives demand for secure, in-house software deployments.
By Phase Insights
How did the Phase III Segment Dominate the Market in 2025?
The phase III segment dominated the clinical trials support software solutions market in 2025 due to the large-scale, complex nature of late-stage trials. Phase III studies involve extensive patient recruitment, multiple sites, and rigorous regulatory requirements, driving high demand for centralized management, data tracking, and performance monitoring. The need for efficient trials oversight, risk management, and timely reporting made phase III the leading segment in software adoption.
The phase I segment is expected to grow at the fastest CAGR during the forecast period due to increasing early-stage drug development and rising clinical research activity. Phase I trials require precise patient monitoring, dose optimization, and safety assessment, driving demand for advanced trial management software. Adoption of digital solutions for data collection, real-time analytics, and streamlined workflows accelerates efficiency, fueling rapid growth in this segment.
By End-User Insights
Why the CROs Segment Dominated the Clinical Trials Support Software Solutions Market?
The CROs segment dominated the market due to their extensive role in managing end-to-end clinical trial operations for pharmaceutical and biotechnology companies. CROs rely heavily on software for study planning, site management, patient recruitment, and regulatory compliance. High trial volumes, demand for operational efficiency, and the need for centralized data management across multiple clients contributed to the segment's market leadership in 2025.
The biopharmaceutical companies
Strengthen your strategy with a dedicated research partner -What are the Recent Developments in the Clinical Trials Support Software Solutions Market
- In June 2025, Medpace collaborated with Voximetry to integrate Torch, an AI-powered dosimetry tool, into radiopharmaceutical trials. Using Voximetry's GPU-accelerated cloud platform, the solution enables accurate, patient-specific radiation dose calculations, improving safety assessments and enhancing the efficiency of clinical trial operations. In June 2024, IQVIA introduced One Home, a comprehensive platform aimed at streamlining decentralized clinical trials. By combining patient-focused tools, services, and centralized data management, the solution simplifies trial operations, enhances efficiency, and accelerates study execution through a unified, easy-to-use digital environment.
Key Players List
- Cytel Inc. (acquired by Nordic Capital and Astorg) Dassault Systemes Veeva Systems IQVIA Castor Saama Oracle Parexel International Corporation Clario (formerly Bioclinica and ERT) RealTime Software Solutions, LLC Curebase Suvoda LLC (merged with Greenphire in April 2025) ICON Plc Medidata Thermo Fisher Scientific Inc.
Browse More Insights of Towards Healthcare:
The global clinical trial software market
The global clinical trial imaging market
The global clinical trial services market
The global clinical trial design market
The global clinical trial central lab services market
The global clinical trial biorepository and archiving solutions market
The clinical trial investigative site network market
The clinical trial supply and logistics market
The global clinical trial supplies market
The global clinical trials market
Segments Covered in the Report
By Product
- Electronic Clinical Outcome Assessment (eCOA) / ePRO) Electronic Data Capture (EDC) & CDMS Clinical Analytics Platforms Clinical data integration platforms Safety solutions Clinical Trial Management System (CTMS) Randomization and Trial Supply Management (RTSM) Electronic Trial Master File (eTMF) eConsent Payments / Investigator Payments Solutions Electronic Investigator Site File (eISF) Patient Matching / Feasibility Solutions
By Delivery Mode
- Cloud and Web-Based On-Premise
By Phase Outlook
- Phase I Phase II Phase III Phase IV (Post-marketing)
By End Use Outlook
- Hospitals/Healthcare Providers/Healthcare providers Contract Research Organizations (CROs) (R&D covered) Academic & Research Institutions Pharmaceutical Companies Biopharmaceutical Companies Medical Device Companies
By Region
- North America
- U.S. Canada
- UK Germany France Italy Spain Denmark Sweden Norway
- Japan China India South Korea Australia Thailand
- Brazil Mexico Argentina
- South Africa Saudi Arabia UAE Kuwait
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard:About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research You can place an order or ask any questions, please feel free to contact us at ...Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web:Our Trusted Data Partners
Precedence Research | Towards Packaging | Towards Food and Beverages | Towards Chemical and Materials | Towards Dental | Towards EV Solutions | Healthcare Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestExplore Further:
/insights/us-clinical-trial-imaging-market-sizing /insights/oncology-clinical-trial-market-sizing /insights/central-lab-market-size /insights/small-nucleic-acid-drug-market-sizing /insights/europe-central-lab-market-sizing /insights/gene-therapy-clinical-trials-market-sizing /insights/apac-clinical-trials-market-sizing /insights/e-clinical-trials-market-sizing /insights/latin-america-clinical-trials-market-sizing /insights/hiv-clinical-trials-market-sizing /insights/europe-clinical-trials-market-sizing /insights/ai-in-clinical-trials-or-drugs-market-sizing
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment